Tyson Popp, vice president, global sourcing and Americas supply chain, West Pharmaceutical Services, Inc., has been formally elected president of the Drug, Chemical & Associated Technologies Association (DCAT) by the membership. He assumed the office on November 1, 2012.  Also elected to serve as officers were  Lyra Myers, associate director and value creation agent, Genentech, George Svokos, senior vice president, product and portfolio management, Teva Pharmaceuticals USA, Inc. and Folker Ruchatz, vice president, global business management custom synthesis, BASF.

Laying the Groundwork for Your Governance, Risk and Compliance (GRC) Journey
Learn from Johnson & Johnson about the foundational elements needed to meet your broader GRC goals
Presented By: Isabel Smith, Director of IA & eGRC Program, Johnson & Johnson, Inc and Shellye Archambeau, CEO, MetricStream
Date: Wednesday June 27, 2012
Time: 8 am Pacific | 11 am Eastern
Duration: 1 hour
Link to register:
http://info.metricstream.com/GRC-life-sciences.html?utm_source=Campaigns&utm_medium=Email&utm_campaign=LSL_June27_WC_LifeSciences_JJ_Webinar&Cid=70150000000cYKP&Channel=Webinar_
In this changing regulatory environment, it becomes important for organizations to start thinking about an enterprise-wide initiative that can bring order and structure to the complexity of complying with industry specific regulations (such as FDA, HIPAA, HITECH) and cross-industry mandates (such as the FCPA, UK Anti-Bribery Act, IT Privacy and Security Laws, SOX). This initiative, called the Enterprise GRC (Governance, Risk & Compliance) Strategy, involves tracking regulatory changes, implementing controls, managing risks, carrying out audits, and defining and ensuring policy conformance in a unified manner.